The association effect of insulin and clonazepam on oxidative stress in liver of an experimental animal model of diabetes and depression

Pharmaceutical Biology

Volumn 51, Issue 5, 2013, Pages 533-538

  Wayhs, Carlos Alberto Yasin ^a,b   Tortato, Caroline ^c   Mescka, Caroline Paula ^c   Pasquali, Matheus Augusto ^c   Schnorr, Carlos Eduardo ^c   Nin, Maurício Schüler ^d   Barros, Helena Maria Tannhauser ^d   Moreira, José Claudio Fonseca ^c   Vargas, Carmen Regla ^a,b,c  

^a Programa de Pós Graduação em Medicina   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Carbonyl; Catalase; Free radicals; Glyoxalase I; Superoxide dismutase

Indexed keywords

CARBONYL DERIVATIVE; CATALASE; CLONAZEPAM; INSULIN; LACTOYLGLUTATHIONE LYASE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME ASSAY; FORCED SWIMMING TEST; GLUCOSE BLOOD LEVEL; LIVER; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES;

ANIMALS; CATALASE; CLONAZEPAM; DEPRESSION; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; INSULIN; LACTOYLGLUTATHIONE LYASE; LIVER; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TIME FACTORS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84876585049     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2012.747544     Document Type: Article

References (40)

1. Aebi H. (1984). Catalase in vitro. Methods Enzymol 105: 121-6.
2. Altomare E, Grattagliano I, Vendemaile G, et al. (1997). Oxidative protein damage in human diabetic eye: Evidence of a retinal participation. Eur J Clin Invest 27: 141-7. (Pubitemid 27101386)
3. Baynes JW. (2003). Chemical modification of proteins by lipids in diabetes. Clin Chem Lab Med 41: 1159-65. (Pubitemid 37265694)
4. Bonnefont-Rousselot D, Beaudeux JL, Therond P, et al. (2004). Diabetes mellitus, oxidative stress and advanced glycation endproducts. Ann Pharm Fr 62: 147-57. (Pubitemid 38849729)
5. Bouwman V, Adriaanse MC, Van 'T Riet E, et al. (2010). Depression, anxiety and glucose metabolism in the general Dutch population: The new Hoorn study. PLoS One 5: 1-7.
6. Brownlee M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-20. (Pubitemid 34000785)
7. Cakatay U. (2005). Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 31: 551-7. (Pubitemid 43001172)
8. Ceriello A, Morocutti A, Mercuri F, et al. (2000). Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 49: 2170-7.
9. Coskun O, Kanter M, Korkmaz A, Oter S. (2005). Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res 51: 117-23. (Pubitemid 40040541)
10. Da Silva Haeser A, Sitta A, Barschak AG, et al. (2007). Oxidative stress parameters in diabetic rats submitted to forced swimming test: The clonazepam effect. Brain Res 1154: 137-43. (Pubitemid 46856340)
11. Di Naso FC, Simoes Dias A, Porawski M, Marroni NA. (2011). Exogenous superoxide dismutase: Action on liver oxidative stress in animals with streptozotocin-induced diabetes. Exp Diabetes Res 2011: 754132.
12. Essani NA, Mcguire GM, Manning AM, Jaeschke H. (1996). Endotoxininduced activation of the nuclear transcription factor kappa B and expression of E-selection messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo. J Immunol 156: 2956-63. (Pubitemid 126660644)
13. Gomez R, Barros HM. (2000). Ethopharmacology of the antidepressant effect of clonazepam in diabetic rats. Pharmacol Biochem Behav 66: 329-35. (Pubitemid 30394619)
14. Gonzalez JS, Peyrot M, Mccarl LA, et al. (2008). Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care 31: 2398-403.
15. Hilakivi-Clarke LA, Wozniak KM, Durcan MJ, Linnoila M. (1990). Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression. Physiol Behav 48: 429-33. (Pubitemid 20325167)
16. Katon W, Lin EH, Kroenke K. (2007). The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 29: 147-55.
17. Kim KM, Kim YS, Jung DH, et al. (2011). Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose. Exp Cell Res 318: 152-9.
18. Kocic R, Pavlovic D, Kocic G. (2007). Impact of intensive insulin treatment on the development and consequences of oxidative stress in insulin-dependent diabetes mellitus. Vojnosanit Pregl 64: 623-8.
19. Kono Y, Fridovich I. (1982). Superoxide radical inhibits catalase. J Biol Chem 257: 5751-4.
20. Levine RL, Garland D, Oliver CN, et al. (1990). Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186: 464-78. (Pubitemid 20279989)
21. Lorenzi R, Andrades ME, Bortolin RC, et al. (2010). Circulating glycolaldehyde induces oxidative damage in the kidney of rats. Diabetes Res Clin Pract 89: 262-7.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-75.
23. Lustman PJ, Anderson RJ, Freedland KE, et al. (2000). Depression and poor glycemic control: A meta-analytic review of the literature. Diabetes Care 23: 934-42. (Pubitemid 30480020)
24. Mannervik B, Aronsson AC, Marmstal E, Tibbelin G. (1981). Glyoxalase I (rat liver). Methods Enzymol 77: 297-301.
25. Matsumoto T, Ozawa Y, Taguchi K, et al. (2010). Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction. Peptides 31: 346-53.
26. Misra HP, Fridovich I. (1972). The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247: 3170-5.
27. Morishita S. (2009). Clonazepam as a therapeutic adjunct to improve the management of depression: A brief review. Hum Psychopharmacol 24: 191-8.
28. Pan HZ, Zhang H, Chang D, et al. (2008). The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92: 548-51. (Pubitemid 351497989)
29. Porsolt RD, Le Pichon M, Jalfre M. (1977). Depression: A new animal model sensitive to antidepressant treatments. Nature 266: 730-2. (Pubitemid 8073804)
30. Rabbani N, Thornalley PJ. (2011). Glyoxalase in diabetes, obesity and related disorders. Semin Cell Dev Biol 22: 309-17.
31. Ren XY, Li YN, Qi JS, Niu T. (2008). Peroxynitrite-induced protein nitration contributes to liver mitochondrial damage in diabetic rats. J Diabetes Complications 22: 357-64.
32. Robles GI, Sigh-Franco D. (2009). A review of exenatide as adjuntive therapy in patients with type 2 diabetes. Drug Des Devel Ther 3: 219-40.
33. Sadi G, Guray T. (2009). Gene expressions of Mn-SOD and GPx-1 in streptozotocin-induced diabetes: Effect of antioxidants. Mol Cell Biochem 327: 127-34.
34. Telci A, Cakatay U, Salman S, et al. (2000). Oxidative protein damage in early stage Type 1 diabetic patients. Diabetes Res Clin Pract 50: 213-23.
35. Wayhs CA, Manfredini V, Sitta A, et al. (2010a). Protein and lipid oxidative damage in streptozotocin-induced diabetic rats submitted to forced swimming test: The insulin and clonazepam effect. Metab Brain Dis 25: 297-304.
36. Wayhs CA, Manfredini V, Sitta A, et al. (2010b). Effects of insulin and clonazepam on DNA damage in diabetic rats submitted to the forced swimming test. Mutat Res 703: 187-90.
37. Wiernsperger NF. (2003). Oxidative stress as a therapeutic target in diabetes: Revisiting the controversy. Diabetes Metab 29: 579-85. (Pubitemid 38082159)
38. Wu JC, Li XH, Peng YD, et al. (2011). Association of two glyoxalase 1 gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes. J Endocrinol Invest 34: 343-8.
39. Yilmaz HR, Uz E, Yucel N, et al. (2004). Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J Biochem Mol Toxicol 18: 234-8. (Pubitemid 39341509)
40. Zimmet P, Alberti KG, Shaw J. (2001). Global and societal implications of the diabetes epidemic. Nature 414: 782-7. (Pubitemid 34000780)